Rates of p16 ( MTS1 ) Mutations in Primary Tumors with 9p Loss-Reference-Cited by-同舟云学术

Rates of p16 ( MTS1 ) Mutations in Primary Tumors with 9p Loss

Published:1994-07-15 Issue:5170 Volume:265 Page:415-417
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Cairns Paul¹,Mao Li¹,Merlo Adrian¹,Lee Daniel J.¹,Schwab Donna¹,Eby Yolanda¹,Tokino Kaori¹,van der Riet Peter¹,Blaugrund James E.¹,Sidransky DaWf¹

Affiliation:

1. Department of Otolaryngology-Head and Neck Surgery, Head and Neck Cancer Research Division, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2196, USA

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference26 articles.

1. Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas

2. CAIRNS, P, PRELIMINARY MAPPING OF THE DELETED REGION OF CHROMOSOME-9 IN BLADDER-CANCER, CANCER RESEARCH 53: 1230 (1993).

3. CAIRNS, P, HOMOZYGOUS DELETIONS OF 9P21 IN PRIMARY HUMAN BLADDER-TUMORS DETECTED BY COMPARATIVE MULTIPLEX POLYMERASE CHAIN-REACTION, CANCER RESEARCH 54: 1422 (1994).

4. Assignment of a Locus for Familial Melanoma, MLM, to Chromosome 9p13-p22

5. COLEMAN, A, DISTINCT DELETIONS OF CHROMOSOME-9P ASSOCIATED WITH MELANOMA VERSUS GLIOMA, LUNG-CANCER, AND LEUKEMIA, CANCER RESEARCH 54: 344 (1994).

Cited by 423 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Pathology according to p53 Pathway;Pathobiology;2023-11-14

2. P16 immunohistochemistry is a sensitive and specific surrogate marker for CDKN2A homozygous deletion in gliomas;Acta Neuropathologica Communications;2023-05-03

3. Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder;World Journal of Surgical Oncology;2023-02-25

4. Current Management and Future Perspective in Pleural Mesothelioma;Cancers;2022-02-18

5. Activation of PPARγ in bladder cancer via introduction of the long arm of human chromosome 9;Oncology Letters;2022-01-27